ESEva Krishna Sutedja

Eva Krishna Sutedja

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Eva Krishna Sutedja has a total of 83 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Clinical and Diagnostic Insights into Penile Angiolymphoid Hyperplasia with Eosinophilia Based on a Case and Analysis of Previous Literature

    by Rievanda Ayu Natasya, Retno Hesty Maharani, Eva Krishna Sutedja, Hermin Aminah Usman, Hanifah Nurul Huda, Pati Aji Achdiat

    Angiolymphoid hyperplasia with eosinophilia (ALHE) is a rare, benign vascular proliferation of unknown origin. It typically occurs in the head and neck region, but can occasionally manifest in unusual locations, such as the penis. Herein, we report a case of ALHE in a 46‐year‐old HIV‐infected male presenting with multiple pruritic whitish nodules on the penile shaft with a size ranging from 0.5 × 0.5 × 0.1 cm to 1.1 × 0.6 × 0.2 cm, initially suspected to be nodular condyloma lata. However, negative serological syphilis test results excluded this initial diagnosis. Histopathological findings were consistent with ALHE, revealing plump endothelial cells and inflammatory infiltrates consisting of lymphocytes and eosinophils. The lesions did not fully resolve with topical corticosteroid therapy, thus necessitating surgical excision. As with ALHE at other sites, recurrence is to be anticipated. Although the pathogenesis remains unclear, an association between ALHE and HIV has been reported. ALHE presents both diagnostic and therapeutic challenges, particularly when it occurs in sensitive areas, such as the penis. While the penis is an atypical site for ALHE, awareness of this disease is important for dermatologists, and it should be included in the differential diagnosis of a penile nodule.

  • Open Access

    Inverted Follicular Keratosis in Young Adult: A Rare Entity in the Differential Diagnosis of Skin Tumors

    by Eva Krishna Sutedja, Endang Sutedja, Kartika Ruchiatan, Yuri Yogya, Yogi Faldian, Oki Suwarsa, Risa Miliawati Nurul Hidayah, Hermin Aminah Usman, Erza Rahayu

    Introduction: Inverted follicular keratosis (IFK) is a rare benign tumor arising from the follicular infundibulum, typically presenting as a solitary lesion on the head and neck of older adults. The actual incidence of inverted follicular keratosis is likely underreported due to frequent misdiagnosis as more common cutaneous lesions, including seborrheic keratosis, verruca vulgaris, or pyogenic granuloma. Case Presentation: We reported a rare case of IFK in a 26-year-old male with a solitary, asymptomatic, pedunculated lesion on the scalp. The patient presented with a 0.7 cm-sized lesion demonstrating intermittent bleeding and slow growth over three years. The lesion was initially diagnosed clinically as a pyogenic granuloma, reflecting its solitary skin lesion and bleeding tendency. On dermoscopy, white structureless amorphous areas with amorphous central keratinous plugs and blood spots were seen. The diagnosis of inverted follicular keratosis was established following histopathological examination, which revealed characteristic features of IFK, including endophytic proliferation and squamous eddies. This case underscores the diagnostic complexity of IFK, which can mimic both benign and malignant cutaneous tumors. Conclusion: IFK, while rare in young patients, should remain a differential diagnosis for scalp lesions across all age groups. Recognition of its dermoscopic and histopathologic features is critical to avoid misclassification and to guide appropriate management. Histopathologic assessment remains essential for establishing a definitive diagnosis.


  • Open Access

    Otosyphilis and Malignant Syphilis in a Human Immunodeficiency Virus–Infected Patient: A Case of Bilateral Hearing Loss with Complete Recovery Following Ceftriaxone Therapy – Case Report

    by Pati Achdiat, Rievanda Natasya, Eva Sutedja, Chaerani Firdaus, Ayu Sabila, Retno Maharani

    Syphilis is characterized by diverse manifestations, including rare complications such as otosyphilis and malignant syphilis, particularly in immunocompromised individuals. This study reported a case of a 40-year-old Human Immunodeficiency Virus (HIV)-positive male with bilateral sensorineural hearing loss (SNHL) and disseminated ulceronodular skin lesions. Serological testing confirmed active Treponema pallidum infection with a venereal disease research laboratory (VDRL) titer of 1:64. Dermatological results were consistent with malignant syphilis, a rare and aggressive variant of secondary syphilis. Audiological assessment showed mild bilateral SNHL, while cerebrospinal fluid analysis was insignificant. Although histopathological confirmation was not performed due to rapid clinical improvement, a presumptive diagnosis of otosyphilis was made. The patient was treated with intramuscular ceftriaxone 2 grams daily for 14 days as an alternative to penicillin due to accessibility constraints and preference. This led to complete resolution of hearing loss, regression of cutaneous lesions, and a significant clinical serological response, including VDRL seroconversion at 6 months. The treatment did not produce Jarisch–Herxheimer reaction, showing good tolerance and supporting ceftriaxone effectiveness as an alternative therapy in HIV-associated syphilis. This case study underscores the importance of early recognition and treatment of otosyphilis and malignant syphilis in HIV-infected individuals. Ceftriaxone may serve as an effective alternative regimen to penicillin, achieving both clinical and serological recovery. Moreover, routine screening for otologic symptoms in patient with syphilis is critical to prevent irreversible complications. The limitations include the absence of histopathology and CSF analysis conducted after therapy initiation.

  • Open Access

    Skin Metastasis from Cervical Adenocarcinoma with Intrapulmonary Metastasis and Metachronous Ovarian Cancer Responding to Chemotherapy: A Case Report and Review

    by Eva Sutedja, Endang Sutedja, Kartika Ruchiatan, Yogi Faldian, Oki Suwarsa, Rafithia Anandita, Hermin Usman, Nur Mala Il Ala

    Skin metastasis, a rare occurrence in cervical cancer, typically signifies advanced systemic disease with a poor prognosis. This case report presents a 55-year-old female with recurrent cervical adenocarcinoma, intrapulmonary metastasis, and metachronous mucinous ovarian cancer who developed skin metastasis. The patient presented with skin-colored and hyperpigmented plaques and papules on the lower abdomen. The histopathological examination of the skin lesion from the patient in this case report revealed subepithelial tumor masses composed of round to oval cells growing hyperplastically in compact clusters, with some forming glandular structures. The nuclei exhibited pleomorphism, ranging from hyperchromatic to vesicular, with clear nucleoli, and mitotic figures were observed. The fibrocollagenous stroma appeared partly edematous, while the skin adnexa, including the sweat and sebaceous glands, remained intact. Immunohistochemical staining for p16 in the skin lesion showed strong positivity in stromal tumor cell infiltrates and negativity in the papillary epithelium, supporting a metastatic origin from cervical adenocarcinoma, confirming the diagnosis of skin metastasis from adenocarcinoma. She was treated with three cycles of paclitaxel and carboplatin chemotherapy, resulting in thinning and a reduction in the size and number of plaques and papules. Despite the positive therapeutic response, the overall prognosis remains poor, and she passed away 16 months after the initial appearance of skin metastasis. This case underscores the importance of routine skin examination in cervical cancer patients, as skin metastasis often correlates with advanced disease and distant organ involvement. Early biopsy and prompt treatment may enhance progression-free survival in such cases.


  • Open Access

    Clinical Experience and Pitfalls in Using Glycyrrhizic Acid for Treating Anogenital Warts in an HIV-Infected Patient in Indonesia: A Case Report

    by Ravika Arrum, Retno Maharani, Eva Sutedja, Laila Tsaqilah, Hendra Gunawan, Pati Aji Achdiat

    Anogenital warts (AGW) are a common manifestation of human papillomavirus (HPV) infection, primarily caused by strains 6 and 11. According to results, mucosal HPV is transmitted through sexual contact, with risk factors including immunodeficiency, such as Human Immunodeficiency Virus (HIV). Individuals with HIV experience a higher incidence of AGW due to impaired immune function that hinders HPV clearance. There is currently no specific antiviral therapy available for HPV, although several management options exist. However, some of these treatments may cause pain and discomfort. Glycyrrhizinic acid (GA) has demonstrated potential in managing HPV infection because of its antiviral properties and minimal side effects. Despite these promising results, GA is not yet recognized as a standard therapy for AGW. This case report describes the effectiveness of Glizigen® (topical GA) combined with Viusid® (oral GA) in managing genital warts in a 28-year-old homosexual male living with HIV. The patient, examined by a dermatologist at Dr. Hasan Sadikin General Hospital, Bandung, Indonesia, presented with perianal warts that had developed over 3 months. According to the physical examination carried out, multiple flesh-colored papules were reported, while histopathological analysis showed koilocytes, and polymerase chain reaction (PCR) confirmed HPV types 6 and 11. The treatment process, carried out using topical and oral GA, was administered from August to October 2024. The improvement was reported only in smaller lesions, while larger ones persisted, leading to electrocautery scheduling. The limited response observed in this case might be influenced by the patient’s low CD4+ count, which potentially affects HPV clearance. Factors such as age, number of sexual partners, circumcision status, HPV type, and anatomical location of the lesions may also have played a role.

  • Open Access

    A Presumptive Case of Mucocutaneous and Visceral Leishmaniasis in Nonendemic Country

    by Hendra Gunawan, Risa Miliawati Nurul Hidayah, Miranti Pangastuti, Oki Suwarsa, Srie Prihianti Gondokaryono, Eva Krishna Sutedja, Marshel Budiarsa, Fitri Yulianti, Yovita Hartantri, Hermin Aminah Usman, et al.

    Leishmaniasis is a complex disease caused by Leishmania parasites and transmitted through the bite of infected sandflies, that is classified into cutaneous leishmaniasis (CL), mucocutaneous leishmaniasis (MCL), and visceral leishmaniasis (VL). The increase in international travel has resulted in cases of leishmaniasis emerging in nonendemic regions, often creating challenges in diagnosis. We report a case of presumptive MCL and VL in a 20-year-old female who complained of multiple skin rashes on the face and body, accompanied by erosions on the lips and eyes. A physical examination showed erosions on the eyes, lips, vulva, and “volcanic” noduloulcerative skin lesions covered with adherent crusts on the face, neck, upper and lower extremities. A biopsy of the skin lesion revealed structures resembling Leishman-Donovan bodies, then the diagnosis of MCL was established. The patient was given 200 mg/day of itraconazole. On the 12th day of itraconazole treatment, the patient experienced shortness of breath and was hospitalized in the Internal Medicine Department. The laboratory examination showed anemia, thrombocytosis, elevated C-reactive protein, and elevated erythrocyte sedimentation rate levels. Computed tomography of the thorax revealed ground-glass opacity, suggestive of lung inflammation. Bone marrow aspiration showed features of hemophagocytic lymphohistiocytosis, and abdominal ultrasound revealed hepatomegaly. The patient was subsequently diagnosed with VL and was treated with amphotericin B. Unfortunately, the patient died due to respiratory failure. Diagnosing leishmaniasis in nonendemic countries is challenging due to the lack of diagnostic tools to identify the protozoa. Dermatologists must recognize clinical signs, be familiar with supportive examinations, and proficiently treat suspected leishmaniasis.


  • Open Access

    Intralesional Botulinum Toxin A for Keloid Treatment: A Review of Efficacy, Safety, and Clinical Applications

    by Eva Sutedja, Endang Sutedja, Kartika Ruchiatan, Yogi Faldian, Dyah Ismiranty, Ananda Putri

    Background: Keloids are fibroproliferative disorders characterized by excessive scarring, functional impairment, and aesthetic concerns. Despite the availability of various treatments, recurrence rates remain high, highlighting the need for alternative therapies with favorable safety profiles. Botulinum toxin A (BTX-A) has emerged as a potential option for keloid treatment; however, its therapeutic role is still not fully elucidated. The aim of this study was to evaluate the efficacy and safety of BTX-A in the treatment of keloids through a structured review of available literature. Methods: This literature review was conducted from three scientific databases: PubMed, Scopus, and Cochrane. The following keywords used were “botulinum toxin”, “BTX-A”, “botulinum toxin A”, and “keloids”. Original studies published in English between 2014 and 2024 that involved human subjects and investigated the use of BTX-A in the treatment of keloids were included. Results: A total of eleven randomized controlled trials were included in this review. Of these, eight studies reported statistically significant improvements in keloid characteristics such as height, pliability, and vascularity following intralesional BTX-A treatment, as measured by validated scales like the Vancouver Scar Scale (VSS). Two studies demonstrated comparable efficacy between BTX-A and intralesional triamcinolone acetonide (TAC). Adverse events were rare and generally limited to mild local reactions. In addition, BTX-A has been shown to be safe for use as a keloid therapy even in the pediatric population. Conclusion: BTX-A showed satisfactory efficacy and safety. In addition, BTX-A showed significant improvement in subjective symptoms in keloid lesions, making BTX-A a promising alternative option for keloid therapy.


  • Open Access

    Cutis verticis gyrata in a Patient with Familial presenile sebaceous hyperplasia Presenting as “Leonine facies”: A Rare Case

    by Eva Sutedja, Endang Sutedja, Kartika Ruchiatan, Yogi Faldian, Yuri Yogya, Reiva Dwiyana, Retno Maharani, Marshel Budiarsa

    Cutis verticis gyrata (CVG) is a rare dermatological disorder characterized by thickened, gyriform folds and ridges of the skin, predominantly affecting the head and face. Based on etiology, it is classified into primary and secondary forms. Familial presenile sebaceous hyperplasia (FPSH), a rare variant of sebaceous hyperplasia, follows an autosomal dominant inheritance pattern with incomplete penetrance and variable severity among family members. We report a case of a 60-year-old male who presented to the Dermatology and Venereology Department, Hasan Sadikin General Hospital, Bandung, with thick plaques and deep furrows on the forehead, giving a “leonine facies” appearance. These lesions first appeared 25 years ago and progressively increased in number and spread to the neck and chest. Similar symptoms were observed in his twin brother and son. Investigations including skin slit smears, blood tests, serum biochemistry, imaging, and testosterone levels were unremarkable. Histopathological examination of facial papules and nodules showed enlarged sebaceous glands in the dermis, supporting the diagnosis of sebaceous hyperplasia. The patient was diagnosed with FPSH associated with CVG. Although rare, both conditions may be linked to systemic abnormalities, highlighting the importance of comprehensive evaluation. There is no definitive treatment for FPSH or CVG; current management is mainly cosmetic. Isotretinoin, with its sebocyte-suppressing effect, may reduce gland size but has a high recurrence rate upon discontinuation. Early recognition and a multidisciplinary approach are crucial to prevent further progression, particularly in older patients.

  • Open Access

    Lichen Planus Pigmentosus as a Cutaneous Extrahepatic Manifestation of Chronic Hepatitis C Virus Infection: A Case Report

    by Erda Avriyanti, Nur Mala Il Ala, Endang Sutedja, Laila Tsaqilah, Chaerani Pratiwi Firdaus, Eva Krishna Sutedja, Hermin Aminah Usman, Risa Miliawati Nurul Hidayah

    Lichen planus pigmentosus is an uncommon dermatological condition characterized by hyperpigmented and dark-brown macules. It is a rare variant of lichen planus, one of the most common cutaneous extrahepatic manifestations of chronic hepatitis C virus infection. The cutaneous extrahepatic manifestations may indicate an undetected chronic hepatitis C virus infection, showing the need for thorough evaluation in patients presenting with these dermatological conditions. This case report presents a case of lichen planus pigmentosus in a 60-year-old male, initially complained of an itchy dark brown macule on his right temple, which progressively enlarged, covered almost the entire face, and became thicker in several areas. Then, he was diagnosed with chronic hepatitis C virus infection and liver cirrhosis. Dermoscopy examination showed gray-brown dots, globules, and peri-eccrine gray-brown pigmented dots. Laboratory tests revealed low ferritin levels, a positive antinuclear antibody test, but a negative antinuclear antibody profile. The histopathological examination showed basal vacuolar changes on the epidermis and interface dermatitis extending to the area of the hair follicle infundibulum, with melanin pigment deposits between the fibro-collagen connective tissue accompanied by inflammatory and peri-adnexa lymphocytes, and fibrosis around the hair follicles in the dermis, supporting the diagnosis of lichen planus pigmentosus. The patient was treated with sun avoidance and photoprotection, mometasone furoate 0.1% cream twice a day, and direct-acting antiviral agents. Improvement was observed clinically and supported by spectrophotometry examination. This case highlights lichen planus pigmentosus as a potential indicator of previously undetected hepatitis C virus infection, recommending hepatitis C virus testing for patients with lichen planus pigmentosus.


  • Open Access

    Undifferentiated Pleomorphic Sarcoma Of The Face: A Rare And Challenging Dermatologic Presentation

    by Zulfan Zulfan, Eva Krishna Sutedja, Endang Sutedja, Kartika Ruchiatan, Yuri Yogya, Yogi Faldian, Reiva Farah Dwiyana, Retno Hesty Maharani

    Undifferentiated pleomorphic sarcoma (UPS) is a rare and aggressive soft tissue malignancy, accounting for less than 1% of all soft tissue sarcomas. It is characterized by a high risk of metastasis and local recurrence, with diagnosis dependent on histopathological and immunohistochemical findings. This case report presents a rare instance of UPS and highlights the diagnostic complexity associated with its atypical presentation. A 48-year-old woman presented with pruritic, erythematous lesions on the forehead and a longstanding, hyperpigmented lesion on the left cheek. The forehead and ear lesions were unresponsive to topical treatments. Physical examination revealed multiple hyperpigmented macules and nodules with sanguine crusts. Histopathological examination showed a connective tissue stroma infiltrated by polymorphic cells, including lymphocytes, histiocytes, and plasma cells. Immunohistochemical analysis revealed focal positivity for CD31, CD34, CD68, and Ki-67, with negativity for CK, CD45, CD117, and Chromogranin. These findings were consistent with UPS. Radiologic imaging suggested pulmonary metastasis, and a secondary bacterial infection was identified. The patient was started on mupirocin for the secondary infection. Due to suspected pulmonary metastasis, surgical excision and radiotherapy were not pursued, and she began doxorubicin-based chemotherapy. Unfortunately, the patient passed away during the second cycle of chemotherapy. UPS is a rare and aggressive sarcoma that presents diagnostic challenges. Despite treatment, the prognosis remains poor due to its metastatic potential and limited response to conventional therapies. Keyword: undifferentiated pleomorphic sarcoma, diagnostic challenges, immunohistochemistry